mescaline has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Appel, JB; Callahan, PM | 1 |
| Gouzoulis-Mayfrank, E; Hermle, L; Spitzer, M | 1 |
| Baker, LE; Taylor, MM | 1 |
| Kovar, KA | 1 |
| Check, E | 1 |
| Sessa, B | 1 |
| Nichols, D | 1 |
| Benzenhöfer, U; Passie, T | 1 |
| Azatsian, K; Gergs, U; Hofmann, B; Höhm, C; Neumann, J | 1 |
| Daily, JE; Nicol, GE; Perry, DA; Siegel, JS | 1 |
| Arias, D; Jones, G; Nock, M | 1 |
| Jones, G; Lipson, J; Wang, E | 1 |
| Holstein, A; Klumpers, LE; Knowles, R; Mantuani, D; Tagen, M; van Heerden, L | 1 |
3 review(s) available for mescaline and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Chemistry and pharmacology of hallucinogens, entactogens and stimulants.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Central Nervous System Stimulants; Hallucinogens; Humans; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Structure-Activity Relationship | 1998 |
MDA, MDMA, and other "mescaline-like" substances in the US military's search for a truth drug (1940s to 1960s).
Topics: 3,4-Methylenedioxyamphetamine; Animals; Designer Drugs; Drug Evaluation, Preclinical; Hallucinogens; Humans; Mescaline; Military Personnel; N-Methyl-3,4-methylenedioxyamphetamine; United States; World War II | 2018 |
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.
Topics: Hallucinogens; Heart Valve Diseases; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Serotonin | 2023 |
1 trial(s) available for mescaline and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
[Hallucinogen induced psychic disorders. Subjective experiences, psychopathology and differential diagnosis].
Topics: Adolescent; Adult; Comorbidity; Female; Hallucinogens; Humans; Male; Mental Disorders; Mescaline; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Psychiatric Status Rating Scales; Psychoses, Substance-Induced | 1996 |
9 other study(ies) available for mescaline and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Hallucinogens; Lysergic Acid Diethylamide; Male; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains | 1988 |
Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Cocaine; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Food; Generalization, Psychological; Hallucinogens; Lysergic Acid Diethylamide; Male; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Stereoisomerism | 1997 |
Psychedelic drugs: the ups and downs of ecstasy.
Topics: Agaricales; Animals; Anxiety; Brain; Cactaceae; Controlled Clinical Trials as Topic; Female; Hallucinogens; History, 20th Century; History, 21st Century; Humans; Lysergic Acid Diethylamide; Medicine, Traditional; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Phytotherapy; Pilot Projects; Psilocybin; Psychotherapy; Stress Disorders, Post-Traumatic | 2004 |
Can psychedelics have a role in psychiatry once again?
Topics: Hallucinogens; History, 20th Century; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Psychiatry; Psychoses, Substance-Induced | 2005 |
Legal highs: the dark side of medicinal chemistry.
Topics: Amphetamines; Animals; Depression; Designer Drugs; Drug Design; Electronic Mail; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease; Research Personnel; Schizophrenia; Substance-Related Disorders | 2011 |
Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations.
Topics: Animals; Atrial Fibrillation; Ephedrine; Hallucinogens; Heart Atria; Humans; Mescaline; Mice; Myocardial Contraction; N-Methyl-3,4-methylenedioxyamphetamine; Phenylpropanolamine | 2023 |
Psychedelic Drug Legislative Reform and Legalization in the US.
Topics: Adolescent; Aged; Educational Status; Female; Hallucinogens; Humans; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Psilocybin | 2023 |
Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.
Topics: Adolescent; Child; Cross-Sectional Studies; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Suicidal Ideation | 2022 |
Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample.
Topics: Adult; Hallucinogens; Humans; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Social Interaction; Substance Withdrawal Syndrome | 2023 |